𝐁𝐚𝐮𝐬𝐜𝐡 + 𝐋𝐨𝐦𝐛 𝐚𝐜𝐪𝐮𝐢𝐫𝐞𝐬 𝐄𝐥𝐢𝐨𝐬 𝐕𝐢𝐬𝐢𝐨𝐧
👁 Bausch + Lomb has acquired Elios Vision, enhancing its glaucoma treatment portfolio with the innovative Excimer Laser Trabeculostomy (ELIOS) system. This minimally invasive glaucoma surgery (MIGS) technology lowers intraocular pressure by creating microchannels in the eye’s drainage system, offering a safer alternative to traditional surgeries.
👀 With its proven success in Europe and ongoing U.S. clinical trials, ELIOS Vision's technology positions Bausch + Lomb as a leading player in the growing glaucoma treatment market.